• Home
  • Conference Highlights
    • View All Conference Highlights
  • Year in Review / Wrap-Ups
    • Wrap-Ups
    • Year in Review
  • Contact Us
  • Conference Highlights
  • American Society of Clinical Oncology (ASCO)
  • ASCO 2014 – Lung Cancer
American Society of Clinical Oncology (ASCO)

ASCO 2014 – Lung Cancer

NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics
ASCO 2014 – Lung Cancer
Read More ›

Next-Generation TKIs
ASCO 2014 – Lung Cancer
Read More ›

Value-Based Use of Molecular and Genomic Markers
ASCO 2014 – Lung Cancer
Read More ›

New Results with Existing Agents
ASCO 2014 – Lung Cancer
Read More ›

New Molecular Targets for NSCLC
ASCO 2014 – Lung Cancer
Read More ›

Immune Checkpoint Therapy in NSCLC
ASCO 2014 – Lung Cancer
Read More ›

Prophylactic Cranial Irradiation in the Adjuvant Setting in NSCLC
ASCO 2014 – Lung Cancer
Read More ›

Adjuvant Erlotinib in EGFR-Mutated NSCLC
ASCO 2014 – Lung Cancer
Read More ›

Chemoradiotherapy in Locally Advanced, Unresectable NSCLC
ASCO 2014 – Lung Cancer
Read More ›

An ALK Inhibitor in Crizotinib-Resistant NSCLC
ASCO 2014 – Lung Cancer
Read More ›

Page 2 of 3

  • 1
  • 2
  • 3
  • Home
  • Conference Highlights
    • View All Conference Highlights
  • Year in Review / Wrap-Ups
    • Wrap-Ups
    • Year in Review
  • Contact Us


© Amplity, Inc. All Rights Reserved. Privacy Policy